Pritesh Shah
Plus aucun poste en cours
Fortune : 2 M $ au 31/03/2024
Profil
Pritesh Shah worked as a Marketing Director for the Oncology Pipeline at OSI Pharmaceuticals, Inc. He then worked as the Chief Growth Officer at NovoCure Ltd.
from 2022 to 2024.
Prior to his work experience, he earned a graduate degree from Seton Hall University and a doctorate from the University of Maryland.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
NOVOCURE LTD.
0,12% | 07/11/2023 | 124 511 ( 0,12% ) | 2 M $ | 31/03/2024 |
Anciens postes connus de Pritesh Shah
| Sociétés | Poste | Fin |
|---|---|---|
| NOVOCURE LIMITED | Corporate Officer/Principal | 01/01/2024 |
| OSI PHARMACEUTICALS, INC. | Sales & Marketing | - |
Formation de Pritesh Shah
| Seton Hall University | Graduate Degree |
| University of Maryland | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| NOVOCURE LIMITED | Health Technology |
| Entreprise privées | 1 |
|---|---|
OSI Pharmaceuticals, Inc.
 OSI Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology OSI Pharmaceuticals, Inc. manufactured and develope dpharmaceutical drugs. The company was founded in 1983 and was headquartered in Farmingdale, NY. | Health Technology |
